GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 348 filers reported holding GLOBUS MED INC in Q4 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,491,754 | +50.1% | 2,406,682 | +80.0% | 0.03% | +52.9% |
| Q2 2023 | $79,620,637 | +13.0% | 1,337,263 | +7.5% | 0.02% | +13.3% |
| Q1 2023 | $70,463,035 | +17.5% | 1,244,051 | +54.1% | 0.02% | +7.1% |
| Q4 2022 | $59,965,514 | +23.5% | 807,399 | -0.9% | 0.01% | +16.7% |
| Q3 2022 | $48,551,000 | +3.1% | 815,029 | -2.9% | 0.01% | +9.1% |
| Q2 2022 | $47,106,000 | -20.7% | 839,056 | +4.3% | 0.01% | -8.3% |
| Q1 2022 | $59,368,000 | +2.1% | 804,665 | -0.1% | 0.01% | +20.0% |
| Q4 2021 | $58,151,000 | -8.5% | 805,402 | -2.9% | 0.01% | -16.7% |
| Q3 2021 | $63,565,000 | +0.4% | 829,622 | +1.6% | 0.01% | 0.0% |
| Q2 2021 | $63,299,000 | +27.1% | 816,439 | +1.1% | 0.01% | +20.0% |
| Q1 2021 | $49,788,000 | -6.8% | 807,310 | -1.4% | 0.01% | -16.7% |
| Q4 2020 | $53,420,000 | +34.2% | 819,094 | +1.9% | 0.01% | +20.0% |
| Q3 2020 | $39,814,000 | -2.4% | 803,993 | -6.0% | 0.01% | -9.1% |
| Q2 2020 | $40,806,000 | +5.6% | 855,318 | -5.8% | 0.01% | -15.4% |
| Q1 2020 | $38,633,000 | -41.1% | 908,361 | -18.5% | 0.01% | -23.5% |
| Q4 2019 | $65,594,000 | +14.7% | 1,114,019 | -0.4% | 0.02% | +6.2% |
| Q3 2019 | $57,165,000 | +15.4% | 1,118,260 | -4.5% | 0.02% | +14.3% |
| Q2 2019 | $49,524,000 | -15.4% | 1,170,783 | -1.1% | 0.01% | -12.5% |
| Q1 2019 | $58,515,000 | -8.7% | 1,184,288 | -20.0% | 0.02% | -20.0% |
| Q4 2018 | $64,099,000 | -29.3% | 1,481,009 | -7.3% | 0.02% | -13.0% |
| Q3 2018 | $90,669,000 | +10.4% | 1,597,422 | -1.9% | 0.02% | +4.5% |
| Q2 2018 | $82,161,000 | +0.6% | 1,628,227 | -0.7% | 0.02% | -4.3% |
| Q1 2018 | $81,705,000 | +7.1% | 1,639,949 | -11.6% | 0.02% | +15.0% |
| Q4 2017 | $76,270,000 | +8.1% | 1,855,735 | -21.8% | 0.02% | +5.3% |
| Q3 2017 | $70,556,000 | -18.9% | 2,374,025 | -9.5% | 0.02% | -24.0% |
| Q2 2017 | $86,951,000 | +11.7% | 2,622,967 | -0.2% | 0.02% | +13.6% |
| Q1 2017 | $77,878,000 | +22.1% | 2,629,315 | +2.3% | 0.02% | +22.2% |
| Q4 2016 | $63,775,000 | +20.5% | 2,570,504 | +9.6% | 0.02% | +12.5% |
| Q3 2016 | $52,912,000 | -12.5% | 2,344,317 | -7.6% | 0.02% | -11.1% |
| Q2 2016 | $60,486,000 | +20.8% | 2,538,231 | +20.4% | 0.02% | +20.0% |
| Q1 2016 | $50,065,000 | -13.0% | 2,108,002 | +1.9% | 0.02% | -11.8% |
| Q4 2015 | $57,527,000 | +26.0% | 2,067,792 | -6.4% | 0.02% | +21.4% |
| Q3 2015 | $45,651,000 | -21.5% | 2,209,714 | -2.4% | 0.01% | -12.5% |
| Q2 2015 | $58,122,000 | +7.9% | 2,264,201 | +6.1% | 0.02% | +14.3% |
| Q1 2015 | $53,871,000 | -4.2% | 2,134,362 | -9.8% | 0.01% | -6.7% |
| Q4 2014 | $56,236,000 | +76.1% | 2,365,905 | +45.7% | 0.02% | +66.7% |
| Q3 2014 | $31,931,000 | -42.3% | 1,623,357 | -29.8% | 0.01% | +28.6% |
| Q2 2014 | $55,294,000 | +14.0% | 2,311,624 | +26.7% | 0.01% | -46.2% |
| Q1 2014 | $48,513,000 | +26.9% | 1,824,463 | -3.7% | 0.01% | +18.2% |
| Q4 2013 | $38,242,000 | -29.4% | 1,895,091 | -38.9% | 0.01% | +37.5% |
| Q3 2013 | $54,160,000 | +337.6% | 3,101,892 | +322.5% | 0.01% | +100.0% |
| Q2 2013 | $12,377,000 | – | 734,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |